sIL-2R (37, 44, 46, 47), biomarker panels (25, 38, 52), NT-proBNP (39), KL-6 and CRP (46, 50), chitotriosidase (40), ACE and neopterin (44, 46), IL12 and IL18 (26), MMP-12 and ADAMDEC1 (27), SPD for uveitis (28), MMP-14 (29), chitotriosidase (30), AUF1, TIA and NCL mRNA (31), LP and CD4/CD8 ratio (32), B-cell-activating factor (34, 45). This evidence concerns the gene NPPB and uveitis.